MedPath

Spanish BMT4me Usability & Acceptability

Recruiting
Conditions
Bone Marrow Transplant
Interventions
Other: BMT4me
Registration Number
NCT06361173
Lead Sponsor
Nationwide Children's Hospital
Brief Summary

The objective of this project is to trans-create, conduct user testing of a previously developed and piloted mHealth app, and user acceptability with parents of children in the acute phase post-allogeneic hematopoietic stem cell transplant (HSCT). Nationwide Children's Hospital (NCH) will be the primary data collection site and Columbia University Irving Medical Center will be a secondary site.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria

Eligible caregivers must have children who:

  1. Are 0-17 years old
  2. Underwent HCT
  3. Are planned for discharge prior to day 100 post-transplant

Primary caregivers must:

  1. Be Spanish speaking
  2. Be ≥18 years old
  3. Have a smartphone (iOS or Android) capable of downloading apps
Exclusion Criteria

(a) Children or caregivers with pre-existing neurodevelopmental disorder/disability or a pervasive developmental disorder will be excluded from this study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Spanish-speaking caregiversBMT4meSpanish-speaking caregivers recruited from Nationwide Children's Hospital and Columbia University Irving Medical Center to pilot test a Spanish a transcreated version of the BMT4me app
Primary Outcome Measures
NameTimeMethod
Assess app usability using the System Usability Scale (SUS)6/1/24 - 5/1/26

Data collected using the System Usability Scale (SUS) will provide insight to the usability of the Spanish BMT4Me app in its current form. he SUS is a 10-item questionnaire routinely used to evaluate the functionality and acceptability of mHealth apps. The SUS is scored on a scale, giving a score from from 0 to 100 where 100 is considered the highest rating of usability. A score of \> 68 is considered above average.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Columbia University Irving Medical Center

🇺🇸

New York, New York, United States

Nationwide Children's Hospital

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath